S.A. Hurvitz

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

University of California, Los Angeles(Current)

S.A. Hurvitz is an author at University of California, Los Angeles specializing in oncology, her2-positive breast cancer, and metastatic breast cancer treatment.

Publications per year

2021–2024

Publications

377O A pooled analysis of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-positive (HER2+) metastatic breast cancer (mBC) with brain metastases (BMs) from DESTINY-Breast (DB) -01, -02, and -03

S.A. Hurvitz, Shanu Modi, Wěi Li et al. · Annals of Oncology · 2023 · 58 citations · Full text

Medicine, Oncology, Breast Oncology +15

Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer

S.S. Shachar, G. Curigliano, F.P. Duhoux et al. · UNC Libraries · 2021 · 29 citations · Full text

Medicine, Oncology, Pharmacology +12

218P Vepdegestrant, a proteolysis targeting chimera (PROTAC) estrogen receptor (ER) degrader, plus palbociclib (palbo) in ER+/human epidermal growth factor receptor 2 (HER2)- advanced breast cancer: Updated phase Ib cohort results

E.P. Hamilton, S.A. Hurvitz, Nicholas P. McAndrew et al. · ESMO Open · 2024 · 11 citations · Full text

Medicine, Oncology, Pharmacology +15

1–3 of 3